Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver . NICE HealthTech guidance 575
National Institute for Health and Care Excellence (NICE)
Record ID 32018012266
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/htg575
Year Published:
2021
URL for published report:
https://www.nice.org.uk/guidance/htg575
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
England
MeSH Terms
- Liver Neoplasms
- Antineoplastic Agents, Alkylating
- Melphalan
- Chemotherapy, Cancer, Regional Perfusion
- Infusions, Intra-Arterial
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
3rd floor, 3 Piccadilly Place, Manchester, M1 3BN
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.